Signet Financial Management LLC purchased a new position in HCA Healthcare Inc (NYSE:HCA) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,332 shares of the company’s stock, valued at approximately $137,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of HCA. FMR LLC increased its holdings in HCA Healthcare by 54.9% in the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after buying an additional 1,944,961 shares during the last quarter. LSV Asset Management increased its holdings in HCA Healthcare by 9.2% in the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after buying an additional 457,752 shares during the last quarter. Schwab Charles Investment Management Inc. increased its holdings in HCA Healthcare by 5.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 1,222,343 shares of the company’s stock worth $125,413,000 after buying an additional 64,426 shares during the last quarter. Swiss National Bank increased its holdings in HCA Healthcare by 1.9% in the second quarter. Swiss National Bank now owns 926,222 shares of the company’s stock worth $95,030,000 after buying an additional 17,500 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its holdings in HCA Healthcare by 5.2% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 897,543 shares of the company’s stock worth $92,088,000 after buying an additional 44,766 shares during the last quarter. 70.40% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts recently commented on the company. Morgan Stanley increased their price objective on HCA Healthcare from $115.00 to $124.00 and gave the stock an “underweight” rating in a report on Wednesday. BMO Capital Markets restated a “buy” rating and issued a $155.00 price objective (up previously from $145.00) on shares of HCA Healthcare in a report on Wednesday. ValuEngine downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, June 28th. Barclays assumed coverage on HCA Healthcare in a report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 price objective on the stock. Finally, SunTrust Banks increased their price objective on HCA Healthcare to $150.00 and gave the stock a “positive” rating in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $123.05.
Shares of HCA stock opened at $134.03 on Wednesday. HCA Healthcare Inc has a 12 month low of $71.18 and a 12 month high of $138.18. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36. The company has a market cap of $46.41 billion, a price-to-earnings ratio of 20.34, a P/E/G ratio of 1.21 and a beta of 0.53.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company had revenue of $11.53 billion for the quarter, compared to the consensus estimate of $11.32 billion. During the same quarter last year, the company posted $1.73 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. sell-side analysts anticipate that HCA Healthcare Inc will post 9.23 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Tuesday, September 4th will be issued a dividend of $0.35 per share. The ex-dividend date is Friday, August 31st. This represents a $1.40 annualized dividend and a yield of 1.04%. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.
In other news, SVP Kathryn A. Torres sold 1,530 shares of the firm’s stock in a transaction on Friday, July 27th. The shares were sold at an average price of $124.47, for a total value of $190,439.10. Following the sale, the senior vice president now owns 9,307 shares in the company, valued at $1,158,442.29. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Charles J. Hall sold 34,125 shares of the firm’s stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $129.93, for a total transaction of $4,433,861.25. Following the completion of the sale, the insider now owns 98,124 shares in the company, valued at approximately $12,749,251.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 209,507 shares of company stock worth $25,305,075. 2.80% of the stock is currently owned by corporate insiders.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: Average Daily Trade Volume – What You Need to Know
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.